Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD)

P. Kopinski, B. Balicka-Slusarczyk, G. Przybylski, A. Jarzemska, G. Pinis, J. Garlicki, M. Krawczyk, J. Szczeklik (Bydgoszcz, Krakow, Poland)

Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session: Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session type: Thematic Poster Session
Number: 1863
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kopinski, B. Balicka-Slusarczyk, G. Przybylski, A. Jarzemska, G. Pinis, J. Garlicki, M. Krawczyk, J. Szczeklik (Bydgoszcz, Krakow, Poland). Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD). Eur Respir J 2008; 32: Suppl. 52, 1863

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012

Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Effect of pirfenidone (PFD) on cytokine/chemokine release from alveolar macrophages (AMs) in interstitial lung diseases (ILD): Preliminary results
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM)
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Cigarette smoke induces peribronchial lymphoid follicles in the absence of TLR4 signalling
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006


Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

Roflumilast N-oxide (RNO) decreases neutrophil adhesion to human bronchial epithelial cells (BEAS-2B) induced by cigarette smoke condensate (CSC) in vitro
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010

Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005

Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Cigarette smoking increases apoptosis of alveolar lymphocytes: data from control group and sarcoidosis patients
Source: Annual Congress 2007 - The versatile aspects of nicotine addiction
Year: 2007


Influence of smoking habit on static lung compliance (Cst) in interstitial lung diseases (ILD) patients
Source: Eur Respir J 2002; 20: Suppl. 38, 194s
Year: 2002

Effect of cigarette smoke on peripheral blood Th17 (PBTh17) cells from COPD patients. Role of acetylcholine
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012

Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Active clinical pulmonary sarcoidosis is characterized by significantly reduced apoptosis rate of alveolar lymphocytes (AL)
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020

Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Source: Eur Respir J 2005; 25: 626-633
Year: 2005



Effect of diesel exhaust particles (DEP) on monocyte-derived macrophage (MDM) mediator release and phagocytosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Source: Eur Respir J 2001; 17: 946-953
Year: 2001